150 related articles for article (PubMed ID: 37100874)
1. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Ebisch RMF; Melchers WJG; Bekkers RLM; Molijn AC; Quint WG; van Kemenade F; Meijer CJLM; Berkhof J; Heideman DAM
Br J Cancer; 2023 Jul; 129(1):104-111. PubMed ID: 37100874
[TBL] [Abstract][Full Text] [Related]
2. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
[TBL] [Abstract][Full Text] [Related]
3. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
[TBL] [Abstract][Full Text] [Related]
4. Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
Vink FJ; Meijer CJLM; Lissenberg-Witte BI; Visser C; Duin S; Snyman LC; Richter KL; van der Merwe FH; Botha MH; Steenbergen RDM; Dreyer G
Clin Infect Dis; 2023 Feb; 76(3):416-423. PubMed ID: 36366827
[TBL] [Abstract][Full Text] [Related]
5. Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer WW; Van Zummeren M; Novianti PW; Richter KL; Verlaat W; Snijders PJ; Heideman DA; Steenbergen RD; Dreyer G; Meijer CJ
J Int AIDS Soc; 2018 Aug; 21(8):e25165. PubMed ID: 30101434
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
7. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
8. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
[TBL] [Abstract][Full Text] [Related]
9. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
[TBL] [Abstract][Full Text] [Related]
10. Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.
Dick S; Heideman DAM; Mom CH; Meijer CJLM; Berkhof J; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Dec; 153(12):2011-2018. PubMed ID: 37539971
[TBL] [Abstract][Full Text] [Related]
11. Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
Vink FJ; Steenbergen RDM; Kremer WW; Lissenberg-Witte BI; Heideman DAM; Bleeker MCG; van Zummeren M; Breytenbach E; Visser C; Lukhwareni A; Meijer CJLM; Dreyer G
AIDS; 2022 Jun; 36(7):953-961. PubMed ID: 35152224
[TBL] [Abstract][Full Text] [Related]
12. Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
De Strooper LMA; Verhoef VMJ; Berkhof J; Hesselink AT; de Bruin HME; van Kemenade FJ; Bosgraaf RP; Bekkers RLM; Massuger LFAG; Melchers WJG; Steenbergen RDM; Snijders PJF; Meijer CJLM; Heideman DAM
Gynecol Oncol; 2016 May; 141(2):341-347. PubMed ID: 26921784
[TBL] [Abstract][Full Text] [Related]
13. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
Snoek BC; Verlaat W; Babion I; Novianti PW; van de Wiel MA; Wilting SM; van Trommel NE; Bleeker MCG; Massuger LFAG; Melchers WJG; Sie D; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM
Int J Cancer; 2019 Jan; 144(2):372-379. PubMed ID: 30192375
[TBL] [Abstract][Full Text] [Related]
15. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
16. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.
Dick S; Verhoef L; De Strooper LM; Ciocănea-Teodorescu I; Wisman GBA; Meijer CJ; Bleeker MC; Steenbergen RD; Heideman DA
Epigenomics; 2020 Sep; 12(18):1569-1578. PubMed ID: 32938193
[No Abstract] [Full Text] [Related]
19. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
20. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
